Substantial reduction in the clinical and economic burden of disease following variant-adapted mRNA COVID-19 vaccines in immunocompromised patients in France

Related articles

1. Economic Evaluation of Pneumococcal Vaccination in Egypt: Cost-Effectiveness, Budget Impact, and Domestic Manufacturing Potential

   This article has 9 authors:

   1. Chrissy Bishop
   2. Arnold Hagens
   3. Federico Cairoli
   4. Konstantina Politopoulou
   5. Zicheng Wang
   6. Motuma Abeshu
   7. Sowmya Kadandale
   8. Ibironke Oyatoye
   9. Saadia Farrukh

2. An HLA Association With COVID-19 Vaccine Reactogenicity Correlates With Fewer SARS-CoV-2 Infections and Monocyte Activation

   This article has 35 authors:

   1. Jill Hollenbach
   2. Anshika Srivastava
   3. Demetra Chatzileontiadou
   4. Anurag Adhikari
   5. Rayo Suseno
   6. Sean Lin
   7. Juliano Boquett
   8. Jamie Tuibeo
   9. Tasneem Yusufali
   10. Noah Peyser
   11. Ticiana Farias
   12. Katherine Kichula
   13. Andrea Nguyen
   14. Irvin Jose
   15. Dhilshan Jayasinghe
   16. Katerina Tarassi
   17. Elissavet Kontou
   18. Janesha Maddumage
   19. Kleio Ampelakiotou
   20. Alexandra Tsirogianni
   21. Michael Dewar-Oldis
   22. Peter Barnard
   23. Joe Sabatino
   24. Dimitrios Zoulas
   25. Emily Ariens
   26. Timothy Mercer
   27. Emma Grant
   28. Lloyd D'Orsogna
   29. Corey Smith
   30. Paul Norman
   31. Gregory Marcus
   32. Jeffrey Olgin
   33. Mark J. Pletcher
   34. Martin Maiers
   35. Stephanie Gras

3. Do mRNA vaccines accelerate the progression of chronic kidney disease? For six years experience

   This article has 2 authors:

   1. Türker EMRE
   2. Fatoş METE